| 26 Jun 2008 |
The European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) Concludes Review of ARCOXIA™ (etoricoxib) |
| |
| 04 Jun 2008 |
New Jersey Supreme Court Dismisses Medical Monitoring Suit Filed by VIOXX® Plaintiffs |
| |
| 29 May 2008 |
Merck Wins Appeal of First VIOXX® Case to go to Trial |
| |
| 20 May 2008 |
Merck Resolves Investigations Under State Consumer Protection Statutes Related to VIOXX |
| |
| 14 May 2008 |
Merck Wins Appeal in VIOXX® Case |
| |
| 05 May 2008 |
Merck to Reduce U.S. Sales Force by 1,200 Positions |
| |
| 01 May 2008 |
Merck Extends Enrollment Deadline in Program to Resolve U.S. VIOXX® Product Liability Lawsuits |
| |
| 15 Apr 2008 |
Merck Responds to Journal of the American Medical Association Articles |
| |
| 03 Mar 2008 |
Merck Progress Report on Enrollment in Program to Resolve U.S. VIOXX® Product Liability Lawsuits |
| |
| 28 Feb 2008 |
Merck Retains Interest in AstraZeneca LP Products |
| |
| 07 Feb 2008 |
Merck Resolves Federal and State Investigations Related to Certain Past Pricing And Certain Past Sales and Marketing Activities |
| |
| 17 Dec 2007 |
Harry Jacobson, M.D., Elected to Merck Board of Directors |
| |
| 05 Dec 2007 |
World Bank and Merck & Co., Inc., Announce U.S. $50 Million Funding Initiative to Eliminate River Blindness in Africa |
| |
| 27 Nov 2007 |
Merck Announces First-Quarter 2008 Dividend |
| |
| 26 Nov 2007 |
Thomas H. Glocer Elected to Merck Board of Directors |
| |
| 26 Nov 2007 |
GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR® (lovastatin) from Merck & Co., Inc. |
| |
| 09 Nov 2007 |
Merck Agreement to Resolve U.S. VIOXX® Product Liability Lawsuits |
| |
| 09 Nov 2007 |
Merck & Co., Inc. Conference Call and Audio Web Cast |
| |
| 01 Nov 2007 |
The Merck/Merial Manual for Pet Health Gives Pet Owners a Trusted Reference for Keeping Their Animals Healthy and Happy |
| |
| 05 Oct 2007 |
Merck Wins Product Liability Case in Florida Circuit Court |
| |
| 27 Sep 2007 |
Merck's GARDASIL and JANUVIA Receive Prix Galien USA Top Honors |
| |
| 19 Sep 2007 |
Steven F. Goldstone Elected to Merck Board of Directors |
| |
| 17 Sep 2007 |
Merck & Co., Inc. Response to New York Medicaid Suit |
| |
| 11 Sep 2007 |
Merck & Co., Inc. Announces Completion of NovaCardia, Inc. Acquisition |
| |
| 06 Sep 2007 |
New Jersey High Court Denies Nationwide Class-Action Status to Insurance Companies Seeking VIOXX® Reimbursements |
| |
| 26 Jul 2007 |
Merck Names Kenneth C. Frazier as President, Global Human Health |
| |
| 25 Jul 2007 |
Merck & Co., Inc. to Acquire NovaCardia, Inc., to Boost Clinical Pipeline of Cardiovascular Drug Candidates |
| |
| 12 Jul 2007 |
ARIAD and Merck & Co., Inc. Announce Global Collaboration to Jointly Develop and Commercialize AP23573 - ARIAD's Novel mTOR Inhibitor - for Cancer |
| |
| 29 Jun 2007 |
Merck Names Peter Kellogg as Executive Vice President and Chief Financial Officer |
| |
| 27 Jun 2007 |
SurModics and Merck Enter Ophthalmic License and Research Collaboration Agreement |
| |
| 20 May 2007 |
Merck Announces Resignation of Peter Loescher, President, Global Human Health |
| |
| 04 May 2007 |
Merck & Co., Inc. Statement on Brazilian Government's Decision To Issue Compulsory License for STOCRIN™ |
| |
| 24 Apr 2007 |
Merck's Plan to Win Has Company Poised to Reclaim Position as Industry Leader, Chairman and CEO Tells Stockholders |
| |
| 20 Apr 2007 |
Texas Court Dismisses Claim of VIOXX® User Who Said Merck Failed to Properly Warn of the Alleged Risks |
| |
| 13 Apr 2007 |
Federal Court Dismisses VIOXX® Securities Class Action |
| |
| 27 Mar 2007 |
Merck Wins Product Liability Case in Madison County, Ill. |
| |
| 26 Mar 2007 |
Merck and Schering-Plough to Develop Another New Cholesterol Lowering Medicine |
| |
| 12 Mar 2007 |
Merck & Co., Inc. to Appeal Humeston VIOXX® Verdict |
| |
| 08 Mar 2007 |
Eighty Percent of Older Americans Live With a Chronic Disease, New Report Finds |
| |
| 05 Mar 2007 |
Dr. Darryle Schoepp, Internationally-Recognized Scientist and Researcher, Joins Merck Research Laboratories in Key Leadership Role |
| |
| 02 Mar 2007 |
N.J. VIOXX® Product Liability Trial Proceeds to Second Phase |
| |
| 20 Feb 2007 |
Merck CFO Judy C. Lewent Plans to Retire in July |
| |
| 16 Feb 2007 |
Merck & Co., Inc. To Distribute ATRIPLA™ in Developing Countries |
| |
| 14 Feb 2007 |
Merck Settles Tax Dispute with Internal Revenue Service |
| |
| 14 Feb 2007 |
Merck & Co., Inc., Again Reduces Price of STOCRIN (efavirenz) For Patients in Least Developed Countries and Countries Hardest Hit by Epidemic |
| |
| 22 Jan 2007 |
Plaintiff Drops VIOXX® Suit against Merck Five Weeks Before First Trial in Philadelphia State Court |
| |
| 18 Jan 2007 |
VIOXX® Plaintiffs Failed to Prove Their Cases: Mistrials Declared In Two California VIOXX Product Liability Cases |
| |
| 17 Jan 2007 |
Merck Chemist Dr. Arthur A. Patchett (Retired) Receives 2007 National Academy of Sciences Award for Chemistry in Service to Society for Contributions to Cardiovascular Medicines |
| |
| 29 Dec 2006 |
Merck & Co., Inc. Announces Completion of Acquisition of Sirna Therapeutics, Inc. |
| |
| 21 Dec 2006 |
Merck and Vertex Announce Start of Pivotal Phase 2 Clinical Trial for Investigational Aurora Kinase Inhibitor MK-0457 (VX-680) in Patients with Treatment-Resistant Forms of Advanced Leukemias |
| |
| 20 Dec 2006 |
Richard T. Clark Elected Chairman of Merck & Co., Inc. |
| |
| 15 Dec 2006 |
Merck Wins Alabama VIOXX® Product Liability Case |
| |
| 14 Dec 2006 |
Merck & Co. and Sirna Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting Period for the Proposed Acquisition of Sirna by Merck |
| |
| 13 Dec 2006 |
Merck Wins Federal VIOXX® Product Liability Case |
| |
| 11 Dec 2006 |
Merck & Co., Inc. and Idera Pharmaceuticals Sign Collaboration Agreement Incorporating Idera's Toll-like Receptor Agonists in Merck's Vaccine Programs |
| |
| 08 Dec 2006 |
Merck and Healthy Interactions Announce Collaboration to Transform Diabetes Patient Education |
| |
| 04 Dec 2006 |
Merck and Neuroptix Collaborate on Early Alzheimer's Diagnostics Using Laser Eye Scanning |
| |
| 22 Nov 2006 |
Statement Regarding Dismissal of Personal Injury Class-Action Lawsuit |
| |
| 16 Nov 2006 |
Advinus Therapeutics and Merck & Co., Inc. Establish Drug Discovery and Development Collaboration |
| |
| 15 Nov 2006 |
Merck Wins Federal VIOXX® Product Liability Case |
| |
| 15 Nov 2006 |
Merck & Co., Inc. Conference Call and Audio Web Cast |
| |
| 03 Nov 2006 |
Merck & Co., Inc. Introduces New 14th Edition of The Merck Index, with Companion CD-ROM |
| |
| 02 Nov 2006 |
Gladstone Institutes and Merck & Co., Inc. Announce Major Research Collaboration and Exclusive License Agreement in Field of Apolipoprotein (Apo) E |
| |
| 30 Oct 2006 |
Merck & Co., Inc. to Acquire Sirna Therapeutics, Inc. |
| |
| 24 Oct 2006 |
Texas Plaintiff Drops VIOXX® Suit against Merck Two Weeks before Trial |
| |
| 12 Oct 2006 |
Ambrilia Biopharma and Merck & Co., Inc. Sign Licensing Agreement Granting Merck Worldwide Rights to Ambrilia's HIV/AIDS Protease Inhibitor Program |
| |
| 09 Oct 2006 |
Bristol-Myers Squibb, Gilead Sciences and Merck & Co. Submit Marketing Authorisation Application for ATRIPLA™ (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) to European Medicines Agency |
| |
| 27 Sep 2006 |
Merck and FoxHollow Technologies Expand Scope of Worldwide Strategic Research Collaboration |
| |
| 26 Sep 2006 |
Merck Wins Federal VIOXX® Product Liability Case: Smith v. Merck & Co., Inc. |
| |
| 26 Sep 2006 |
Merck & Co., Inc. Conference Call and Audio Web Cast |
| |
| 17 Aug 2006 |
Expanded Access Program for MK-0518, an Investigational HIV Integrase Inhibitor, Established for Patients with Limited Available Treatment Options |
| |
| 17 Aug 2006 |
Merck & Co., Inc. Conference Call and Audio Web Cast |
| |
| 17 Aug 2006 |
Merck Disagrees with New Jersey State Judge's Decision to Set Aside 2005 Defense Verdict in Humeston v. Merck, Company is Considering Legal Options |
| |
| 17 Aug 2006 |
Merck to Appeal Federal VIOXX® Verdict in Barnett v. Merck |
| |
| 16 Aug 2006 |
Dr. Luciano Rossetti, Internationally-Recognized Physician and Researcher, Joins Merck Research Laboratories in Key Leadership Role |
| |
| 02 Aug 2006 |
Merck Wins First California VIOXX® Case |
| |
| 02 Aug 2006 |
Merck & Co., Inc. Conference Call and Audio Web Cast |
| |
| 13 Jul 2006 |
Merck & Co., Inc. Conference Call and Audio Web Cast |
| |
| 13 Jul 2006 |
Merck Wins New Jersey VIOXX® Product Liability Case |
| |
